Skip to the page

Data / Form D filings / Aethl Bio, Inc.

Aethl Bio, Inc.: Form D filing

Aethl Bio, Inc., a biotechnology company in Pittsburgh, PA, filed a Form D with the SEC in 2026. The latest, on April 17, 2026, reports $1.6 million sold of a $5 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
100 S JACKSON AVE STE 05-526, Pittsburgh, PA, 15202
Phone
(412) 212-6563
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2116929

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 17, 2026New notice$5,000,000$1,635,000$3,365,0008Jul 14, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Carmelo MontalvoExecutive Officer, Director
Zachary RichertDirector
Dan WillisExecutive Officer
Melissa ThompsonExecutive Officer

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Apr 13, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Aethl Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.